Mapping the epidemiology of the male disadvantage in cancer

PhD defence by Fie Stegenborg Andersen

Assessment Committee

Professor Anne-Marie Nybo Andersen, Department of Public Health, University of Copenhagen (Chairperson)
Professor Mette Nørgaard, Department of Clinical Epidemiology, Aarhus University
Professor Georgios Lyratzopoulos, Epidemiology of Cancer Healthcare and Outcomes, University College London

Supervisors

Professor Susanne Oksbjerg Dalton
Professor Henrik Hjalgrim
Associate Professor Pernille Envold Bidstrup

Department

Department of Clinical Medicine

Graduate Programme

Public Health and Epidemiology

Place

Building: 5.1., Room: A.B, Strandboulevarden 49, 2100 Copenhagen

Email address to gain access to the thesis: fieandersen@outlook.dk.
You will either receive a copy of the thesis or be informed where you can read a physical copy.
Recipients of copies of the thesis are not allowed to share or distribute it due to copyright compliance.

Short description of the thesis

Cancer does not affect males and females equally. Males face both a higher risk of developing cancer and poorer chances of survival than females. While growing attention has rightly focused on reducing inequalities in female health, the disadvantage males face when it comes to cancer has received far less attention, both in research, clinical practice, and health policy. Using detailed Danish register data, this PhD project systematically examined differences between males and females across the cancer trajectory, from healthcare contacts before diagnosis and stage at diagnosis to treatment and survival. The thesis adds to the understanding of sex differences in cancer and highlights potential pathways for prevention.